-
1
-
-
0006264020
-
Some physiochemical aspects of iron metabolism
-
Elsevier, North Holland, Amsterdam
-
Aisen, P. 1977. Some physiochemical aspects of iron metabolism. In Iron metabolism. Ciba Foundation Symposium 51, New Series. Elsevier, North Holland, Amsterdam, pp. 1-17.
-
(1977)
Iron Metabolism. Ciba Foundation Symposium 51, New Series
, pp. 1-17
-
-
Aisen, P.1
-
2
-
-
0027930931
-
Iron at the cell surface controls DNA synthesis in CC1 39 cells
-
Alcain, F.J., Löw, H., and Crane, F.L. 1994a. Iron at the cell surface controls DNA synthesis in CC1 39 cells. Biochem. Biophys. Res. Commun. 203: 16-21.
-
(1994)
Biochem. Biophys. Res. Commun.
, vol.203
, pp. 16-21
-
-
Alcain, F.J.1
Löw, H.2
Crane, F.L.3
-
3
-
-
0027989957
-
Iron reverses impermeable chelator inhibition of DNA synthesis in CC1 39 cells
-
Alcain, F.J., Löw, H., and Crane, F.L. 1994b. Iron reverses impermeable chelator inhibition of DNA synthesis in CC1 39 cells. Proc. Natl. Acad. Sci. U.S.A. 91: 7903-7906.
-
(1994)
Proc. Natl. Acad. Sci. U.S.A.
, vol.91
, pp. 7903-7906
-
-
Alcain, F.J.1
Löw, H.2
Crane, F.L.3
-
4
-
-
0002360572
-
Structural studies of Fe(III) and Cu(II) complexes of salicylaldehyde benzoyl hydrazone, a synthetic chelating agent exhibiting diverse biological properties
-
Aruffo, A., Murphy, T.B., Johnson, D.K., Rose, N.J., and Schomaker, V. 1982. Structural studies of Fe(III) and Cu(II) complexes of salicylaldehyde benzoyl hydrazone, a synthetic chelating agent exhibiting diverse biological properties. Inorg. Chim. Acta, 67: L25-L27.
-
(1982)
Inorg. Chim. Acta
, vol.67
-
-
Aruffo, A.1
Murphy, T.B.2
Johnson, D.K.3
Rose, N.J.4
Schomaker, V.5
-
5
-
-
0022386084
-
Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture
-
Baker, E., Vitolo, M.L., and Webb, J.M. 1985. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture. Biochem. Pharmacol. 34: 3011-3017.
-
(1985)
Biochem. Pharmacol.
, vol.34
, pp. 3011-3017
-
-
Baker, E.1
Vitolo, M.L.2
Webb, J.M.3
-
6
-
-
0023763818
-
Iron metabolism and the effect of iron chelators in rat hepatoma cells
-
Baker, E., Lloyd, D.A., Morgan, E.H., and Yeoh, G.C.T. 1988. Iron metabolism and the effect of iron chelators in rat hepatoma cells. Birth Defects, 23(5B): 89-95.
-
(1988)
Birth Defects
, vol.23
, Issue.5 B
, pp. 89-95
-
-
Baker, E.1
Lloyd, D.A.2
Morgan, E.H.3
Yeoh, G.C.T.4
-
7
-
-
0026575576
-
Evaluation of the iron chelation potential of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture
-
Baker, E., Richardson, D.R., Gross, S., and Ponka, P. 1992. Evaluation of the iron chelation potential of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture. Hepatology, 15: 492-501.
-
(1992)
Hepatology
, vol.15
, pp. 492-501
-
-
Baker, E.1
Richardson, D.R.2
Gross, S.3
Ponka, P.4
-
8
-
-
0023087831
-
Release of iron from endosomes is an early step in the transferrin cycle
-
Bakkeren, D.L., de Jeu-Jaspars, C.M.H., Kroos, M.J., and van Eijk, H.G. 1987. Release of iron from endosomes is an early step in the transferrin cycle. Int. J. Biochem. 19: 179-186.
-
(1987)
Int. J. Biochem.
, vol.19
, pp. 179-186
-
-
Bakkeren, D.L.1
De Jeu-Jaspars, C.M.H.2
Kroos, M.J.3
Van Eijk, H.G.4
-
9
-
-
0024241764
-
Deferoxamine inhibition of human neuroblastoma viability and proliferation
-
Becton, D.L., and Bryles, P. 1988. Deferoxamine inhibition of human neuroblastoma viability and proliferation. Cancer Res. 48: 7189-7192.
-
(1988)
Cancer Res.
, vol.48
, pp. 7189-7192
-
-
Becton, D.L.1
Bryles, P.2
-
10
-
-
0024343393
-
Antileukemic effects of desferrioxamine on human myeloid leukemia cell lines
-
Becton, D.L., and Roberts, B. 1989. Antileukemic effects of desferrioxamine on human myeloid leukemia cell lines. Cancer Res. 49: 4809-4812.
-
(1989)
Cancer Res.
, vol.49
, pp. 4809-4812
-
-
Becton, D.L.1
Roberts, B.2
-
11
-
-
0029742532
-
Up-regulation of vascular endothelial growth factor production by iron chelators
-
Becrepoot, L.V., Shima, D.T., Kuroki, M., Yeo, K.T., and Voest, E.E. 1996. Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res. 56: 3747-3751.
-
(1996)
Cancer Res.
, vol.56
, pp. 3747-3751
-
-
Becrepoot, L.V.1
Shima, D.T.2
Kuroki, M.3
Yeo, K.T.4
Voest, E.E.5
-
12
-
-
0023605740
-
Microbial iron chelator-induced cell cycle synchronisation in L1210 cells: Potential in combination chemotherapy
-
Bergeron, R.J., and Ingeno, M.J. 1987. Microbial iron chelator-induced cell cycle synchronisation in L1210 cells: potential in combination chemotherapy. Cancer Res. 47: 6010-6016.
-
(1987)
Cancer Res.
, vol.47
, pp. 6010-6016
-
-
Bergeron, R.J.1
Ingeno, M.J.2
-
13
-
-
0014278271
-
Studies on the mode of action of the copper(II) chelate of 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone)
-
Bhuyan, B., and Betz, T. 1968. Studies on the mode of action of the copper(II) chelate of 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone). Cancer Res. 28: 758-763.
-
(1968)
Cancer Res.
, vol.28
, pp. 758-763
-
-
Bhuyan, B.1
Betz, T.2
-
14
-
-
0023092624
-
Antineuroblastoma activity of desferrioxamine in human cell lines
-
Blatt, J., and Stitely, S. 1987. Antineuroblastoma activity of desferrioxamine in human cell lines. Cancer Res. 47: 1749-1750.
-
(1987)
Cancer Res.
, vol.47
, pp. 1749-1750
-
-
Blatt, J.1
Stitely, S.2
-
15
-
-
0023689207
-
Mechanism of antineuroblastoma activity of deferoxamine in vitro
-
Blatt, J., Taylor, S.R., and Stitely, S. 1988. Mechanism of antineuroblastoma activity of deferoxamine in vitro. J. Lab. Clin. Med. 112: 433-436.
-
(1988)
J. Lab. Clin. Med.
, vol.112
, pp. 433-436
-
-
Blatt, J.1
Taylor, S.R.2
Stitely, S.3
-
16
-
-
0024348430
-
Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines
-
Blatt, J., Taylor, S.R., and Kontoghiorghes, G.J. 1989. Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines. Cancer Res. 49: 2925-2927.
-
(1989)
Cancer Res.
, vol.49
, pp. 2925-2927
-
-
Blatt, J.1
Taylor, S.R.2
Kontoghiorghes, G.J.3
-
17
-
-
0022651531
-
The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukemic cells
-
Bomford, A., Isaac, J., Roberts, S., Edwards, A., Young, S., and Williams, R. 1986. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukemic cells. Biochem. J. 236: 243-249.
-
(1986)
Biochem. J.
, vol.236
, pp. 243-249
-
-
Bomford, A.1
Isaac, J.2
Roberts, S.3
Edwards, A.4
Young, S.5
Williams, R.6
-
18
-
-
0014003948
-
Synergistic action of kethoxal bis(thiosemicarbazone) and cupric ions in Sarcoma 180
-
Booth, B., and Sartorelli, A. 1966. Synergistic action of kethoxal bis(thiosemicarbazone) and cupric ions in Sarcoma 180. Nature (London), 210: 104-105.
-
(1966)
Nature (London)
, vol.210
, pp. 104-105
-
-
Booth, B.1
Sartorelli, A.2
-
19
-
-
0000844115
-
Metabolic effects of copper in intact cells: Comparative activity of cupric chloride and kethoxal bis(thiosemicarbazone)
-
Booth, B., and Sartorelli, A. 1967. Metabolic effects of copper in intact cells: comparative activity of cupric chloride and kethoxal bis(thiosemicarbazone). Mol. Pharmacol. 3: 290-302.
-
(1967)
Mol. Pharmacol.
, vol.3
, pp. 290-302
-
-
Booth, B.1
Sartorelli, A.2
-
20
-
-
0015155548
-
Metabolic effects of zinc in intact cells: Comparative studies of zinc chloride and the zinc chelate of kethoxal bis(thiosemicarbazone)
-
Booth, B., Donnelly, T., Zettner, A., and Sartorelli, A. 1971. Metabolic effects of zinc in intact cells: comparative studies of zinc chloride and the zinc chelate of kethoxal bis(thiosemicarbazone). Biochem. Pharmacol. 20: 3109-3118.
-
(1971)
Biochem. Pharmacol.
, vol.20
, pp. 3109-3118
-
-
Booth, B.1
Donnelly, T.2
Zettner, A.3
Sartorelli, A.4
-
21
-
-
0022256894
-
Iron metabolism in K562 erythroleukemia cells
-
Bottomley, S.S., Wolfe, L.C., and Bridges, K.R. 1985. Iron metabolism in K562 erythroleukemia cells. J. Biol. Chem. 260: 6811-6815.
-
(1985)
J. Biol. Chem.
, vol.260
, pp. 6811-6815
-
-
Bottomley, S.S.1
Wolfe, L.C.2
Bridges, K.R.3
-
22
-
-
0028834446
-
Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II)
-
Breuer, W., Epsztejn, S., and Cabantchik, Z.I. 1995. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270: 24 207-24 215.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 24207-24215
-
-
Breuer, W.1
Epsztejn, S.2
Cabantchik, Z.I.3
-
23
-
-
0021746936
-
Effect of iron chelators on the transferrin receptor in K562 cells
-
Bridges, K.R., and Cudkowicz, A. 1984. Effect of iron chelators on the transferrin receptor in K562 cells. J. Biol. Chem. 259: 12 970-12 977.
-
(1984)
J. Biol. Chem.
, vol.259
, pp. 12970-12977
-
-
Bridges, K.R.1
Cudkowicz, A.2
-
24
-
-
0021261878
-
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
-
Washington, D.C.
-
Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E., and Bishop, J.M. 1984. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington, D.C.), 224: 1121-1124.
-
(1984)
Science
, vol.224
, pp. 1121-1124
-
-
Brodeur, G.M.1
Seeger, R.C.2
Schwab, M.3
Varmus, H.E.4
Bishop, J.M.5
-
25
-
-
0027201502
-
1 phase of the cell cycle
-
1 phase of the cell cycle. Cancer Res. 53: 3968-3975.
-
(1993)
Cancer Res.
, vol.53
, pp. 3968-3975
-
-
Brodie, C.1
Siriwardana, G.2
Lucas, J.3
Schleicher, R.4
Terada, N.5
Szepesi, A.6
Gelfand, E.7
Seligman, P.8
-
26
-
-
0019888660
-
Activated bleomycin: A transient complex of drug, iron and oxygen that degrades DNA
-
Burger, R.M., Peisach, J., and Horwitz, S.B. 1981. Activated bleomycin: a transient complex of drug, iron and oxygen that degrades DNA. J. Biol. Chem. 256: 11 636-11 644.
-
(1981)
J. Biol. Chem.
, vol.256
, pp. 11636-11644
-
-
Burger, R.M.1
Peisach, J.2
Horwitz, S.B.3
-
27
-
-
0022543673
-
Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells
-
Cairo, G., Vezzoni, P., Bardella, L., Schiaffonati, L., Rappocciolo, E., Levi, S., and Arosio, P. 1986. Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells. Biochem. Biophys. Res. Commun. 139: 652-657.
-
(1986)
Biochem. Biophys. Res. Commun.
, vol.139
, pp. 652-657
-
-
Cairo, G.1
Vezzoni, P.2
Bardella, L.3
Schiaffonati, L.4
Rappocciolo, E.5
Levi, S.6
Arosio, P.7
-
28
-
-
0022839492
-
Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells: Mechanisms responsible for the specific cytotoxicity of transferrin-gallium
-
Chitamber, C.R., and Seligman, P.A. 1986. Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells: mechanisms responsible for the specific cytotoxicity of transferrin-gallium. J. Clin. Invest. 78: 1538-1546.
-
(1986)
J. Clin. Invest.
, vol.78
, pp. 1538-1546
-
-
Chitamber, C.R.1
Seligman, P.A.2
-
29
-
-
0029929672
-
Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio
-
Chresta, C.M., Masters, J.R.W., and Hickman, J.A. 1996. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res. 56: 1834-1841.
-
(1996)
Cancer Res.
, vol.56
, pp. 1834-1841
-
-
Chresta, C.M.1
Masters, J.R.W.2
Hickman, J.A.3
-
30
-
-
0018831805
-
Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone
-
Cikrt, M., Ponka, P., Necas, E., and Neuwirt, J. 1980. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone. Br. J. Haematol. 45: 275-283.
-
(1980)
Br. J. Haematol.
, vol.45
, pp. 275-283
-
-
Cikrt, M.1
Ponka, P.2
Necas, E.3
Neuwirt, J.4
-
31
-
-
0029833706
-
The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase
-
Cooper, C.E., Lynagh, G.R., Hoyes, K.P., Hider, R.C., Cammack, R., and Porter, J.B. 1996. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J. Biol. Chem. 271: 20 291-20 299.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 20291-20299
-
-
Cooper, C.E.1
Lynagh, G.R.2
Hoyes, K.P.3
Hider, R.C.4
Cammack, R.5
Porter, J.B.6
-
32
-
-
0021971399
-
Transplasma-membrane redox systems in growth and development
-
Crane, F.L., Sun, I.L., Clarke, M.G., Grebing, C., and Low, H. 1985. Transplasma-membrane redox systems in growth and development. Biochim. Biophys. Acta, 811: 233-264.
-
(1985)
Biochim. Biophys. Acta
, vol.811
, pp. 233-264
-
-
Crane, F.L.1
Sun, I.L.2
Clarke, M.G.3
Grebing, C.4
Low, H.5
-
33
-
-
0015362471
-
Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone
-
DeConti, R.C., Toftness, B.R., Agrawal, K.C., Tomchick, R., Mead, J.A.R., Bertino, J.R., Sartorelli, A.C., and Cressy, W.A. 1972. Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone. Cancer Res. 32: 1455-1462.
-
(1972)
Cancer Res.
, vol.32
, pp. 1455-1462
-
-
Deconti, R.C.1
Toftness, B.R.2
Agrawal, K.C.3
Tomchick, R.4
Mead, J.A.R.5
Bertino, J.R.6
Sartorelli, A.C.7
Cressy, W.A.8
-
34
-
-
0343879405
-
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene
-
Depper, J.M., Leonard, W.J., Drogula, C., Kronke, M., Waldmann, T.A., and Greene, W.C. 1985. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc. Natl. Acad. Sci. U.S.A. 82: 4230-4234.
-
(1985)
Proc. Natl. Acad. Sci. U.S.A.
, vol.82
, pp. 4230-4234
-
-
Depper, J.M.1
Leonard, W.J.2
Drogula, C.3
Kronke, M.4
Waldmann, T.A.5
Greene, W.C.6
-
35
-
-
0024561408
-
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: In vitro and in vivo studies
-
Dezza, L., Cazzola, M., Danova, M., Carlo-Stella, C., Bergamaschi, G., Brugnatelli, S., Invernizzi, R., Mazzini, G., Riccardi, A., and Ascari, E. 1989. Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies. Leukemia, 3: 104-107.
-
(1989)
Leukemia
, vol.3
, pp. 104-107
-
-
Dezza, L.1
Cazzola, M.2
Danova, M.3
Carlo-Stella, C.4
Bergamaschi, G.5
Brugnatelli, S.6
Invernizzi, R.7
Mazzini, G.8
Riccardi, A.9
Ascari, E.10
-
37
-
-
0025126032
-
Effects of a single course of deferoxamine in neuroblastoma patients
-
Donfrancesco, A., Deb, G., Dominici, C., Pileggi, D., Castello, M.A., and Helson, L. 1990. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res. 50: 4929-4930.
-
(1990)
Cancer Res.
, vol.50
, pp. 4929-4930
-
-
Donfrancesco, A.1
Deb, G.2
Dominici, C.3
Pileggi, D.4
Castello, M.A.5
Helson, L.6
-
38
-
-
0026683009
-
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECat): A new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma
-
Donfrancesco, A., Deb, G., Dominici, C., Angioni, A., Caniglia, M., De Sio, L., Fidani, P., Amici, A., and Helson, L. 1992. Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECat): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma. Am. J. Clin. Oncol. 15: 319-322.
-
(1992)
Am. J. Clin. Oncol.
, vol.15
, pp. 319-322
-
-
Donfrancesco, A.1
Deb, G.2
Dominici, C.3
Angioni, A.4
Caniglia, M.5
De Sio, L.6
Fidani, P.7
Amici, A.8
Helson, L.9
-
39
-
-
0029066979
-
Deferoxamine (D) followed by cytoxan (C), etoposide (E), carboplatin (Ca), thio-TEPA (T), induction regimen in advanced neuroblastoma
-
Donfrancesco, A., De Bernardi, B., Carli, M., Mancini, A., Nigro, M., De Sio, L., Casale, F., Bagnulo, S., Helson, L., and Deb, G. 1995. Deferoxamine (D) followed by cytoxan (C), etoposide (E), carboplatin (Ca), thio-TEPA (T), induction regimen in advanced neuroblastoma. Eur. J. Cancer, 31A: 612-615.
-
(1995)
Eur. J. Cancer
, vol.31 A
, pp. 612-615
-
-
Donfrancesco, A.1
De Bernardi, B.2
Carli, M.3
Mancini, A.4
Nigro, M.5
De Sio, L.6
Casale, F.7
Bagnulo, S.8
Helson, L.9
Deb, G.10
-
40
-
-
0030031404
-
Role of desferrioxamine in tumor therapy
-
Donfrancesco, A., Deb, G., De Sio, L., Cozza, R., and Castellano, A. 1996. Role of desferrioxamine in tumor therapy. Acta Haematol. 95: 66-69.
-
(1996)
Acta Haematol.
, vol.95
, pp. 66-69
-
-
Donfrancesco, A.1
Deb, G.2
De Sio, L.3
Cozza, R.4
Castellano, A.5
-
41
-
-
0022461970
-
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involved the iron sulphur prosthetic group and is reversible
-
Drapier, J.C., and Hibbs, J.B., Jr. 1986. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involved the iron sulphur prosthetic group and is reversible. J. Clin. Invest. 78: 790-797.
-
(1986)
J. Clin. Invest.
, vol.78
, pp. 790-797
-
-
Drapier, J.C.1
Hibbs Jr., J.B.2
-
42
-
-
0023135326
-
In vivo and in vitro effects of desferrioxamine in neonatal acute leukemia
-
Estrov, Z., Tawa, A., Wang, X.-H., Dube, I.D., Sulh, H., Cohen, A., Gelfand, E.W., and Freedman, M.H. 1987. In vivo and in vitro effects of desferrioxamine in neonatal acute leukemia. Blood, 69: 757-761.
-
(1987)
Blood
, vol.69
, pp. 757-761
-
-
Estrov, Z.1
Tawa, A.2
Wang, X.-H.3
Dube, I.D.4
Sulh, H.5
Cohen, A.6
Gelfand, E.W.7
Freedman, M.H.8
-
43
-
-
0023752206
-
Synergistic antiproliferative effects on HL-60 cells: Deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity
-
Estrov, Z., Cohen, A., Gelfand, E.W., and Freedman, M.H. 1988. Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity. Am. J. Pediatr. Hematol. Oncol. 10: 288-291.
-
(1988)
Am. J. Pediatr. Hematol. Oncol.
, vol.10
, pp. 288-291
-
-
Estrov, Z.1
Cohen, A.2
Gelfand, E.W.3
Freedman, M.H.4
-
44
-
-
0023161071
-
Prognostic factors in neuroblastoma
-
Evans, A.E., D'Angio, G.J., Propert, K., Anderson, J., and Hann, H.W.L. 1987. Prognostic factors in neuroblastoma. Cancer, 59: 1853-1859.
-
(1987)
Cancer
, vol.59
, pp. 1853-1859
-
-
Evans, A.E.1
D'Angio, G.J.2
Propert, K.3
Anderson, J.4
Hann, H.W.L.5
-
47
-
-
0017726547
-
Selective toxicity induced by picolinic acid in simian virus 4-transformed cells in tissue culture
-
Fernandez-Pol, J.A., and Johnson, G.S. 1977. Selective toxicity induced by picolinic acid in simian virus 4-transformed cells in tissue culture. Cancer Res. 37: 4276-4279.
-
(1977)
Cancer Res.
, vol.37
, pp. 4276-4279
-
-
Fernandez-Pol, J.A.1
Johnson, G.S.2
-
48
-
-
0006113383
-
Control of growth by picolinic acid: Differential response of normal and transformed cells
-
Fernandez-Pol, J.A., Bono, V.H., Jr., and Johnson, G.S. 1977. Control of growth by picolinic acid: differential response of normal and transformed cells. Proc. Natl. Acad. Sci. U.S.A. 74: 2889-2893.
-
(1977)
Proc. Natl. Acad. Sci. U.S.A.
, vol.74
, pp. 2889-2893
-
-
Fernandez-Pol, J.A.1
Bono Jr., V.H.2
Johnson, G.S.3
-
49
-
-
4344561207
-
Differential ferrioxamine test for measuring chelatable body iron
-
Fielding, J. 1965. Differential ferrioxamine test for measuring chelatable body iron. J. Clin. Pathol. 18: 88-97.
-
(1965)
J. Clin. Pathol.
, vol.18
, pp. 88-97
-
-
Fielding, J.1
-
50
-
-
0023577562
-
Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes
-
Forsbeck, K., Nilsson, K., and Kontoghiorghes, G.J. 1987. Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes. Eur. J. Haematol. 39: 318-325.
-
(1987)
Eur. J. Haematol.
, vol.39
, pp. 318-325
-
-
Forsbeck, K.1
Nilsson, K.2
Kontoghiorghes, G.J.3
-
51
-
-
0345336958
-
Iron and N-myc expression in neuroblastoma
-
Philadelphia
-
Frantz, C.N., Iyer, J., Frick, K.K., Eskenazi, A.E., and Derg, P.E. 1993. Iron and N-myc expression in neuroblastoma. Neuroblastoma Research Meeting, Philadelphia.
-
(1993)
Neuroblastoma Research Meeting
-
-
Frantz, C.N.1
Iyer, J.2
Frick, K.K.3
Eskenazi, A.E.4
Derg, P.E.5
-
52
-
-
0344043046
-
Iron chelation cancer therapy for neuroblastoma
-
April 16-21, 1995, Asheville, N.C.
-
Frantz, C.N., Eskenazi, A.E., and Overman, D. 1995. Iron chelation cancer therapy for neuroblastoma. Proceedings of the International Conference on Bioiron. April 16-21, 1995, Asheville, N.C. p. 195.
-
(1995)
Proceedings of the International Conference on Bioiron
, pp. 195
-
-
Frantz, C.N.1
Eskenazi, A.E.2
Overman, D.3
-
53
-
-
0013805463
-
The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone
-
French, F.A., and Blanz, E.J., Jr. 1965. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone. Cancer Res. 25: 1454-1458.
-
(1965)
Cancer Res.
, vol.25
, pp. 1454-1458
-
-
French, F.A.1
Blanz Jr., E.J.2
-
54
-
-
0029379698
-
Iron deprivation results in an increase in p53 expression
-
Fukuchi, K., Tomoyasu, S., Watanabe, H., Kaetsu, S., Tsuruoka, N., and Gomi, K. 1995. Iron deprivation results in an increase in p53 expression. Biol. Chem. Hoppe-Seyler, 376: 627-630.
-
(1995)
Biol. Chem. Hoppe-Seyler
, vol.376
, pp. 627-630
-
-
Fukuchi, K.1
Tomoyasu, S.2
Watanabe, H.3
Kaetsu, S.4
Tsuruoka, N.5
Gomi, K.6
-
56
-
-
0020558257
-
Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free medium
-
Goto, Y., Paterson, M., and Listowsky, I. 1983. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free medium. J. Biol. Chem. 258: 5248-5255.
-
(1983)
J. Biol. Chem.
, vol.258
, pp. 5248-5255
-
-
Goto, Y.1
Paterson, M.2
Listowsky, I.3
-
57
-
-
0016107787
-
The identification of 2,3-dihydroxybenzoic acid as a potentially useful iron chelating drug
-
Graziano, J.H., Grady, R.W., and Cerami, A. 1974. The identification of 2,3-dihydroxybenzoic acid as a potentially useful iron chelating drug. J. Pharmacol. Exp. Ther. 190: 570-575.
-
(1974)
J. Pharmacol. Exp. Ther.
, vol.190
, pp. 570-575
-
-
Graziano, J.H.1
Grady, R.W.2
Cerami, A.3
-
58
-
-
0030755366
-
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
-
Gunshin, H., Mackenzie, B., Berger, U.V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L., and Hediger, M.A. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (London), 388: 482-488.
-
(1997)
Nature (London)
, vol.388
, pp. 482-488
-
-
Gunshin, H.1
Mackenzie, B.2
Berger, U.V.3
Gunshin, Y.4
Romero, M.F.5
Boron, W.F.6
Nussberger, S.7
Gollan, J.L.8
Hediger, M.A.9
-
59
-
-
0027269545
-
A structural role for metal ions in "wild type" conformation of the tumor suppressor protein p53
-
Hainaut, P., and Milner, J. 1993. A structural role for metal ions in "wild type" conformation of the tumor suppressor protein p53. Cancer Res. 53: 1739-1742.
-
(1993)
Cancer Res.
, vol.53
, pp. 1739-1742
-
-
Hainaut, P.1
Milner, J.2
-
60
-
-
0028838002
-
Temperature sensitivity for conformation is an intrinsic property of wild-type p53
-
Hainaut, P., Butcher, S., and Milner, J. 1995. Temperature sensitivity for conformation is an intrinsic property of wild-type p53. Br. J. Cancer, 71: 227-231.
-
(1995)
Br. J. Cancer
, vol.71
, pp. 227-231
-
-
Hainaut, P.1
Butcher, S.2
Milner, J.3
-
61
-
-
0018837540
-
Serum ferritin as a guide to therapy in neuroblastoma
-
Hann, H.-W.L., Howard, M.L., and Evans, A.E. 1980. Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res. 40: 1411-1413.
-
(1980)
Cancer Res.
, vol.40
, pp. 1411-1413
-
-
Hann, H.-W.L.1
Howard, M.L.2
Evans, A.E.3
-
62
-
-
0022593176
-
Source of increased ferritin in neuroblastoma: Studies with concanavalin A - Sepharose binding
-
Hann, H.-W.L., Stahlhut, M.W., and Evans, A.E. 1986. Source of increased ferritin in neuroblastoma: studies with concanavalin A - Sepharose binding. J. Natl. Cancer Inst. 76: 1031-1033.
-
(1986)
J. Natl. Cancer Inst.
, vol.76
, pp. 1031-1033
-
-
Hann, H.-W.L.1
Stahlhut, M.W.2
Evans, A.E.3
-
63
-
-
0025332680
-
Effects of iron and desferrioxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines
-
Hann, H.L., Stahlhut, M.W., and Hann, C.L. 1990. Effects of iron and desferrioxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology, 11: 566-569.
-
(1990)
Hepatology
, vol.11
, pp. 566-569
-
-
Hann, H.L.1
Stahlhut, M.W.2
Hann, C.L.3
-
64
-
-
0026699860
-
Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice
-
Hann, H.-W.L., Stahlhut, M.W., Rubin, R., and Maddrey, W.C. 1992. Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice. Cancer, 70: 2051-2056.
-
(1992)
Cancer
, vol.70
, pp. 2051-2056
-
-
Hann, H.-W.L.1
Stahlhut, M.W.2
Rubin, R.3
Maddrey, W.C.4
-
65
-
-
0030608152
-
The ferritins: Molecular properties, iron storage function and cellular regulation
-
Harrison, P.M., and Arosio, P. 1996. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta, 1275: 161-203.
-
(1996)
Biochim. Biophys. Acta
, vol.1275
, pp. 161-203
-
-
Harrison, P.M.1
Arosio, P.2
-
66
-
-
0026059699
-
Mechanisms of bleomycin-induced lung damage
-
Hay, J., Shahzeidi, S., and Laurent, G. 1991. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65: 81-94.
-
(1991)
Arch. Toxicol.
, vol.65
, pp. 81-94
-
-
Hay, J.1
Shahzeidi, S.2
Laurent, G.3
-
67
-
-
0029758487
-
Molecular control of vertebrate iron metabolism: MRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress
-
Hentze, M.W., and Kühn, L.C. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 93: 8175-8182.
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 8175-8182
-
-
Hentze, M.W.1
Kühn, L.C.2
-
68
-
-
0019518135
-
Mechanisms of in vivo chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal
-
Hershko, C., Avramovici-Grisaru, S., Link, G., Gelfand, L., and Sarel, S. 1981. Mechanisms of in vivo chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal. J. Lab. Clin. Med. 98: 99-108.
-
(1981)
J. Lab. Clin. Med.
, vol.98
, pp. 99-108
-
-
Hershko, C.1
Avramovici-Grisaru, S.2
Link, G.3
Gelfand, L.4
Sarel, S.5
-
69
-
-
0021128761
-
Iron depletion. Possible cause of tumor cell cytotoxicity induced by activated macrophages
-
Hibbs, J.B., Jr., Taintor, R.R., and Vavrin, Z. 1984. Iron depletion. Possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem. Biophys. Res. Commun. 123: 716-723.
-
(1984)
Biochem. Biophys. Res. Commun.
, vol.123
, pp. 716-723
-
-
Hibbs Jr., J.B.1
Taintor, R.R.2
Vavrin, Z.3
-
70
-
-
0024244657
-
Nitric oxide: A cytotoxic activated macrophage effector molecule
-
Hibbs, J.B., Jr., Taintor, R.R., Vavrin, Z., and Rachlin, E.M. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94.
-
(1988)
Biochem. Biophys. Res. Commun.
, vol.157
, pp. 87-94
-
-
Hibbs Jr., J.B.1
Taintor, R.R.2
Vavrin, Z.3
Rachlin, E.M.4
-
71
-
-
0028931345
-
Iron chelators induce apoptosis in proliferating cells
-
Hileti, D., Panayiotidis, P., and Hoffbrand, A.V. 1995. Iron chelators induce apoptosis in proliferating cells. Br. J. Haematol. 89: 181-187.
-
(1995)
Br. J. Haematol.
, vol.89
, pp. 181-187
-
-
Hileti, D.1
Panayiotidis, P.2
Hoffbrand, A.V.3
-
72
-
-
0018567483
-
Effective iron chelation following oral adminstration of an isoniazid pyridoxal hydrazone
-
Hoy, T., Humphreys, J., Jacobs, A., Williams, A., and Ponka, P. 1979. Effective iron chelation following oral adminstration of an isoniazid pyridoxal hydrazone. Br. J. Haematol. 43: 443-449.
-
(1979)
Br. J. Haematol.
, vol.43
, pp. 443-449
-
-
Hoy, T.1
Humphreys, J.2
Jacobs, A.3
Williams, A.4
Ponka, P.5
-
73
-
-
0027486590
-
Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools
-
Hoyes, K.P., and Porter, J.B. 1993. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools. Br. J. Haematol. 85: 393-400.
-
(1993)
Br. J. Haematol.
, vol.85
, pp. 393-400
-
-
Hoyes, K.P.1
Porter, J.B.2
-
74
-
-
0026782447
-
Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemic cell lines
-
Hoyes, K.P., Hider, R.C., and Porter, J.B. 1992. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemic cell lines. Cancer Res. 52: 4591-4599.
-
(1992)
Cancer Res.
, vol.52
, pp. 4591-4599
-
-
Hoyes, K.P.1
Hider, R.C.2
Porter, J.B.3
-
76
-
-
0019505314
-
Interaction of human diferric transferrin with reticulocytes
-
Huebers, H., Csiba, E., Josephson, B., Huebers, E., and Finch, C.A. 1982. Interaction of human diferric transferrin with reticulocytes. Proc. Natl. Acad. Sci. U.S.A. 78: 621-625.
-
(1982)
Proc. Natl. Acad. Sci. U.S.A.
, vol.78
, pp. 621-625
-
-
Huebers, H.1
Csiba, E.2
Josephson, B.3
Huebers, E.4
Finch, C.A.5
-
77
-
-
0020961007
-
The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes
-
Iacopetta, B.J., and Morgan, E.H. 1983. The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes. J. Biol. Chem. 258: 9108-9115.
-
(1983)
J. Biol. Chem.
, vol.258
, pp. 9108-9115
-
-
Iacopetta, B.J.1
Morgan, E.H.2
-
78
-
-
0023898916
-
Neuroblastomas contain iron-rich ferritin
-
Iancu, T.C., Shiloh, H., and Kedar, A. 1988. Neuroblastomas contain iron-rich ferritin. Cancer, 61: 2497-2502.
-
(1988)
Cancer
, vol.61
, pp. 2497-2502
-
-
Iancu, T.C.1
Shiloh, H.2
Kedar, A.3
-
79
-
-
0017700831
-
Low molecular weight intracellular iron transport compounds
-
Jacobs, A. 1977. Low molecular weight intracellular iron transport compounds. Blood, 50: 433-439.
-
(1977)
Blood
, vol.50
, pp. 433-439
-
-
Jacobs, A.1
-
80
-
-
0001525013
-
Cytotoxic chelators and chelates. I. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper(II) complex of salicylaldehyde benzoyl hydrazone
-
Johnson, D.K., Murphy, T.B., Rose, N.J., Goodwin, W.H., and Pickart, L. 1982. Cytotoxic chelators and chelates. I. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper(II) complex of salicylaldehyde benzoyl hydrazone. Inorg. Chim. Acta, 67: 159-165.
-
(1982)
Inorg. Chim. Acta
, vol.67
, pp. 159-165
-
-
Johnson, D.K.1
Murphy, T.B.2
Rose, N.J.3
Goodwin, W.H.4
Pickart, L.5
-
81
-
-
7444249085
-
The biochemistry of deferoxamine and its relation to iron metabolism
-
Keberle, H. 1964. The biochemistry of deferoxamine and its relation to iron metabolism. Ann. N.Y. Acad. Sci. U.S.A. 119: 758-768.
-
(1964)
Ann. N.Y. Acad. Sci. U.S.A.
, vol.119
, pp. 758-768
-
-
Keberle, H.1
-
82
-
-
0025125020
-
Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor
-
Kemp, J.D., Smith, K.M., Kanner, L.J., Gomez, F., Thorson, J.A., and Naumann, P.W. 1990. Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor. Blood, 76: 991-995.
-
(1990)
Blood
, vol.76
, pp. 991-995
-
-
Kemp, J.D.1
Smith, K.M.2
Kanner, L.J.3
Gomez, F.4
Thorson, J.A.5
Naumann, P.W.6
-
83
-
-
0026701955
-
Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: Evidence for a threshold model of iron deprivation toxicity
-
Kemp, J.D., Thorson, J.A., Stewart, B.C., and Naumann, P.W. 1992. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity. Cancer Res. 52: 4144-4148.
-
(1992)
Cancer Res.
, vol.52
, pp. 4144-4148
-
-
Kemp, J.D.1
Thorson, J.A.2
Stewart, B.C.3
Naumann, P.W.4
-
84
-
-
0017834644
-
Serum and tumour ferritins in primary liver cancer
-
Kew, M.C., Torrance, J.D., Derman, D., Simon, M., Macnab, G.M., Charlton, R.W., and Bothwell, T.H. 1978. Serum and tumour ferritins in primary liver cancer. Gut, 19: 294-299.
-
(1978)
Gut
, vol.19
, pp. 294-299
-
-
Kew, M.C.1
Torrance, J.D.2
Derman, D.3
Simon, M.4
Macnab, G.M.5
Charlton, R.W.6
Bothwell, T.H.7
-
85
-
-
0025271438
-
Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: Evidence for the involvement of the hydroxyl radical
-
Keyes, S.M., and Tyrrell, R.M. 1990. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: evidence for the involvement of the hydroxyl radical. Carcinogenesis, 11: 787-791.
-
(1990)
Carcinogenesis
, vol.11
, pp. 787-791
-
-
Keyes, S.M.1
Tyrrell, R.M.2
-
86
-
-
0023115572
-
Effectiveness of oral iron chelators assayed in the rat
-
Kim, B.K., Huebers, H.A., and Finch, C.A. 1987. Effectiveness of oral iron chelators assayed in the rat. Am. J. Hematol. 24: 277-284.
-
(1987)
Am. J. Hematol.
, vol.24
, pp. 277-284
-
-
Kim, B.K.1
Huebers, H.A.2
Finch, C.A.3
-
87
-
-
0020579762
-
Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle
-
Klausner, R.D., Ashwell, G., van Renswoude, J., Harford, J.B., and Bridges, K.R. 1983. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc. Natl. Acad. Sci. U.S.A. 80: 2263-2266.
-
(1983)
Proc. Natl. Acad. Sci. U.S.A.
, vol.80
, pp. 2263-2266
-
-
Klausner, R.D.1
Ashwell, G.2
Van Renswoude, J.3
Harford, J.B.4
Bridges, K.R.5
-
89
-
-
0022453348
-
Iron mobilisation from ferritin using α-oxohydroxy heteroaromatic chelators
-
Kontoghiorghes, G.J. 1986. Iron mobilisation from ferritin using α-oxohydroxy heteroaromatic chelators. Biochem. J. 233: 299-302.
-
(1986)
Biochem. J.
, vol.233
, pp. 299-302
-
-
Kontoghiorghes, G.J.1
-
90
-
-
0021932825
-
Site specificity of iron removal from transferrin by α-ketohydroxypyridone chelators
-
Kontoghiorghes, G.J., and Evans, R.W. 1985. Site specificity of iron removal from transferrin by α-ketohydroxypyridone chelators. FEBS Lett. 189: 141-144.
-
(1985)
FEBS Lett.
, vol.189
, pp. 141-144
-
-
Kontoghiorghes, G.J.1
Evans, R.W.2
-
91
-
-
0022871715
-
Cytotoxic and DNA-inhibitory effects of iron chelators on human leukemic cell lines
-
Kontoghiorghes, G.J., Piga, A., and Hoffbrand, A.V. 1986a. Cytotoxic and DNA-inhibitory effects of iron chelators on human leukemic cell lines. Hematol. Oncol. 4: 195-204.
-
(1986)
Hematol. Oncol.
, vol.4
, pp. 195-204
-
-
Kontoghiorghes, G.J.1
Piga, A.2
Hoffbrand, A.V.3
-
92
-
-
0023009651
-
Cytotoxic effects of the lipophilic iron chelator, omadine
-
Kontoghiorghes, G.J., Piga, A., and Hoffbrand, A.V. 1986b. Cytotoxic effects of the lipophilic iron chelator, omadine. FEBS Lett. 204: 208-212.
-
(1986)
FEBS Lett.
, vol.204
, pp. 208-212
-
-
Kontoghiorghes, G.J.1
Piga, A.2
Hoffbrand, A.V.3
-
93
-
-
0016236741
-
Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP: NSC-107392), with special reference to its Fe chelating properties
-
Krakoff, I.H., Etcubanas, E., Tan, C., Mayer, K., Bethune, V., and Burchenai, J.H. 1974. Clinical trial of 5-hydroxypicolinaldehyde thiosemicarbazone (5-HP: NSC-107392), with special reference to its Fe chelating properties. Cancer Chemother. Rep. 53: 207-212.
-
(1974)
Cancer Chemother. Rep.
, vol.53
, pp. 207-212
-
-
Krakoff, I.H.1
Etcubanas, E.2
Tan, C.3
Mayer, K.4
Bethune, V.5
Burchenai, J.H.6
-
94
-
-
0021840709
-
Sequential expression of genes involved in human T lymphocyte growth and differentiation
-
Kronke, M., Leonard, W.J., Depper, J.M., and Greene, W.C. 1985. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 161: 1593-1598.
-
(1985)
J. Exp. Med.
, vol.161
, pp. 1593-1598
-
-
Kronke, M.1
Leonard, W.J.2
Depper, J.M.3
Greene, W.C.4
-
95
-
-
0000622023
-
Iron-transferrin requirements and transferrin receptor expression in proliferating cells
-
Edited by P. Ponka, H.M. Schulman, and R.C. Woodworth. CRC Press, Boca Raton, Fla.
-
Kühn, L.C., Schulman, H.M., and Ponka, P. 1990. Iron-transferrin requirements and transferrin receptor expression in proliferating cells. In Iron transport and storage. Edited by P. Ponka, H.M. Schulman, and R.C. Woodworth. CRC Press, Boca Raton, Fla. pp. 141-191.
-
(1990)
Iron Transport and Storage
, pp. 141-191
-
-
Kühn, L.C.1
Schulman, H.M.2
Ponka, P.3
-
96
-
-
0021813287
-
Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilisation
-
Laub, R., Schneider, Y.-J., Octave, J.-N., Trouet, A., and Crichton, R.R. 1985. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilisation. Biochem. Pharmacol. 34: 1175-1183.
-
(1985)
Biochem. Pharmacol.
, vol.34
, pp. 1175-1183
-
-
Laub, R.1
Schneider, Y.-J.2
Octave, J.-N.3
Trouet, A.4
Crichton, R.R.5
-
97
-
-
0021259518
-
Deferoxamine: A reversible S phase inhibitor of human lymphocyte proliferation
-
Lederman, H.M., Cohen, A., Lee, J.W.W., Freedman, M.H., and Gelfand, E. W. 1984. Deferoxamine: a reversible S phase inhibitor of human lymphocyte proliferation. Blood, 64: 748-753.
-
(1984)
Blood
, vol.64
, pp. 748-753
-
-
Lederman, H.M.1
Cohen, A.2
Lee, J.W.W.3
Freedman, M.H.4
Gelfand, E.W.5
-
98
-
-
0020076580
-
Antitumor activity of picolinic acid in CBA/J mice
-
Leuthauser, S.W.C., Oberley, L.W., and Oberley, T.D. 1982. Antitumor activity of picolinic acid in CBA/J mice. J. Natl. Cancer Inst. 68: 123-126.
-
(1982)
J. Natl. Cancer Inst.
, vol.68
, pp. 123-126
-
-
Leuthauser, S.W.C.1
Oberley, L.W.2
Oberley, T.D.3
-
99
-
-
0018884431
-
Chelating substances
-
Levinson, W.E. 1980. Chelating substances. Antibiot. Chemother. 27: 288-306.
-
(1980)
Antibiot. Chemother.
, vol.27
, pp. 288-306
-
-
Levinson, W.E.1
-
100
-
-
0016724542
-
Measurement of serum ferritin by radioimmunoassay: Results in normal individuals and patients with breast cancer
-
Marcus, D.M., and Zinberg, N. 1975. Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J. Natl. Cancer Inst. 55: 791-795.
-
(1975)
J. Natl. Cancer Inst.
, vol.55
, pp. 791-795
-
-
Marcus, D.M.1
Zinberg, N.2
-
103
-
-
0026770310
-
Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW613-S human colon carcinoma cell line
-
Modjtahedi, N., Frebourg, T., Fossar, N., Lavialle, C., Cremisi, C., and Brison, O. 1992. Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW613-S human colon carcinoma cell line. Exp. Cell. Res. 201: 74-82.
-
(1992)
Exp. Cell. Res.
, vol.201
, pp. 74-82
-
-
Modjtahedi, N.1
Frebourg, T.2
Fossar, N.3
Lavialle, C.4
Cremisi, C.5
Brison, O.6
-
104
-
-
0023530083
-
Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte
-
Mostert, L.J., van Dorst, J.A.L.M., Koster, J.F., van Eijk, H.G., and Kontoghiorghes, G.J. 1987. Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte. Free Radical Res. Commun. 3: 379-388.
-
(1987)
Free Radical Res. Commun.
, vol.3
, pp. 379-388
-
-
Mostert, L.J.1
Van Dorst, J.A.L.M.2
Koster, J.F.3
Van Eijk, H.G.4
Kontoghiorghes, G.J.5
-
105
-
-
0024276911
-
A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm
-
Müllner, E.W., and Kühn, L.C. 1988. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell, 53: 815-825.
-
(1988)
Cell
, vol.53
, pp. 815-825
-
-
Müllner, E.W.1
Kühn, L.C.2
-
106
-
-
0018236898
-
Ferritin: Structure, biosynthesis and role in iron metabolism
-
Munro, H.N., and Linder, M.C. 1978. Ferritin: structure, biosynthesis and role in iron metabolism. Physiol. Rev. 58: 317-396.
-
(1978)
Physiol. Rev.
, vol.58
, pp. 317-396
-
-
Munro, H.N.1
Linder, M.C.2
-
107
-
-
0023445376
-
Conservation of ferritin heavy subunit gene structure: Implications for the regulation of ferritin gene expression
-
Murray, M.T., White, K., and Munro, H.N. 1987. Conservation of ferritin heavy subunit gene structure: implications for the regulation of ferritin gene expression. Proc. Natl. Acad. Sci. U.S.A. 84: 7438-7442.
-
(1987)
Proc. Natl. Acad. Sci. U.S.A.
, vol.84
, pp. 7438-7442
-
-
Murray, M.T.1
White, K.2
Munro, H.N.3
-
108
-
-
0022979812
-
Role of iron in adriamycin biochemistry
-
Myers, C., Gianni, L., Zweier, J., Muindi, J., Sinha, B.K., and Eliot, H. 1986. Role of iron in adriamycin biochemistry. Fed. Proc. 45: 2792-2797.
-
(1986)
Fed. Proc.
, vol.45
, pp. 2792-2797
-
-
Myers, C.1
Gianni, L.2
Zweier, J.3
Muindi, J.4
Sinha, B.K.5
Eliot, H.6
-
109
-
-
0027521831
-
Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators
-
Nyholm, S., Mann, G.J., Johansson, A.G., Bergeron, R.J., Gräslund, A., and Thelander, L. 1993. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J. Biol. Chem. 268: 26 200-26 205.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 26200-26205
-
-
Nyholm, S.1
Mann, G.J.2
Johansson, A.G.3
Bergeron, R.J.4
Gräslund, A.5
Thelander, L.6
-
110
-
-
0017194077
-
Chelate mediated transfer of iron from transferrin to desferrioxamine
-
Pollack, S., Aisen, P., Laskey, F.D., and Vanderhoff, G. 1976. Chelate mediated transfer of iron from transferrin to desferrioxamine. Br. J. Haematol. 34: 231-235.
-
(1976)
Br. J. Haematol.
, vol.34
, pp. 231-235
-
-
Pollack, S.1
Aisen, P.2
Laskey, F.D.3
Vanderhoff, G.4
-
111
-
-
0018394556
-
Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent
-
Ponka, P., Borova, J., Neuwirt, J., and Fuchs, O. 1979a. Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent. FEBS Lett. 97: 317-321.
-
(1979)
FEBS Lett.
, vol.97
, pp. 317-321
-
-
Ponka, P.1
Borova, J.2
Neuwirt, J.3
Fuchs, O.4
-
112
-
-
0018798539
-
A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents
-
Ponka, P., Borova, J., Neuwirt, J., Fuchs, O., and Necas, E. 1979b. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents. Biochim. Biophys. Acta, 586: 278-297.
-
(1979)
Biochim. Biophys. Acta
, vol.586
, pp. 278-297
-
-
Ponka, P.1
Borova, J.2
Neuwirt, J.3
Fuchs, O.4
Necas, E.5
-
113
-
-
0023780401
-
Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes
-
Ponka, P., Richardson, D., Baker, E., Schulman, H.M., and Edward, J.T. 1988. Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes. Biochim. Biophys. Acta, 967: 122-129.
-
(1988)
Biochim. Biophys. Acta
, vol.967
, pp. 122-129
-
-
Ponka, P.1
Richardson, D.2
Baker, E.3
Schulman, H.M.4
Edward, J.T.5
-
114
-
-
0031963449
-
Function and regulation of transferrin and ferritin
-
Ponka, P., Beaumont, C., and Richardson, D.R. 1998. Function and regulation of transferrin and ferritin. Semin. Hematol. 35: 1-21.
-
(1998)
Semin. Hematol.
, vol.35
, pp. 1-21
-
-
Ponka, P.1
Beaumont, C.2
Richardson, D.R.3
-
115
-
-
0023811903
-
Iron mobilization from hepatocyte monolayer cultures by chelators: The importance of membrane permeability and the iron-binding constant
-
Porter, J.B., Gyparaki, M., Burke, L.C., Huehns, E.R., Sarpong, P., Saez, V., and Hider, R.C. 1988. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant. Blood, 72: 1497-1503.
-
(1988)
Blood
, vol.72
, pp. 1497-1503
-
-
Porter, J.B.1
Gyparaki, M.2
Burke, L.C.3
Huehns, E.R.4
Sarpong, P.5
Saez, V.6
Hider, R.C.7
-
116
-
-
0030998296
-
Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process
-
Richardson, D.R. 1997. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process. Biochim. Biophys. Acta, 1320: 45-67.
-
(1997)
Biochim. Biophys. Acta
, vol.1320
, pp. 45-67
-
-
Richardson, D.R.1
-
117
-
-
0025341256
-
The uptake of iron and transferrin by the human melanoma cell
-
Richardson, D.R., and Baker, E. 1990. The uptake of iron and transferrin by the human melanoma cell. Biochim. Biophys. Acta, 1053: 1-12.
-
(1990)
Biochim. Biophys. Acta
, vol.1053
, pp. 1-12
-
-
Richardson, D.R.1
Baker, E.2
-
118
-
-
0026081935
-
The release of iron and transferrin from the human melanoma cell
-
Richardson, D.R., and Baker, E. 1991. The release of iron and transferrin from the human melanoma cell. Biochim. Biophys. Acta, 1091: 294-302.
-
(1991)
Biochim. Biophys. Acta
, vol.1091
, pp. 294-302
-
-
Richardson, D.R.1
Baker, E.2
-
119
-
-
0026690909
-
Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate
-
Richardson, D.R., and Baker, E. 1992. Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J. Biol. Chem. 267: 13 972-13 979.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 13972-13979
-
-
Richardson, D.R.1
Baker, E.2
-
120
-
-
0027944830
-
Two saturable mechanisms of iron uptake from transferrin human melanoma cells: The effect of transferrin concentration, chelators and metabolic probes on transferrin and iron uptake
-
Richardson, D.R., and Baker, E. 1994. Two saturable mechanisms of iron uptake from transferrin human melanoma cells: the effect of transferrin concentration, chelators and metabolic probes on transferrin and iron uptake. J. Cell. Physiol. 161: 160-168.
-
(1994)
J. Cell. Physiol.
, vol.161
, pp. 160-168
-
-
Richardson, D.R.1
Baker, E.2
-
121
-
-
0030894798
-
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone
-
Richardson, D.R., and Milnes, K. 1997. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood, 89: 3025-3038.
-
(1997)
Blood
, vol.89
, pp. 3025-3038
-
-
Richardson, D.R.1
Milnes, K.2
-
122
-
-
0028535112
-
The iron metabolism of the human neuroblastoma cell. Lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis
-
Richardson, D.R., and Ponka, P. 1994. The iron metabolism of the human neuroblastoma cell. Lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis. J. Lab. Clin. Med. 124: 660-671.
-
(1994)
J. Lab. Clin. Med.
, vol.124
, pp. 660-671
-
-
Richardson, D.R.1
Ponka, P.2
-
123
-
-
0031567095
-
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
-
Richardson, D.R., and Ponka, P. 1997. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta, 1331: 1-40.
-
(1997)
Biochim. Biophys. Acta
, vol.1331
, pp. 1-40
-
-
Richardson, D.R.1
Ponka, P.2
-
124
-
-
0023800613
-
Effects of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture
-
Richardson, D., Baker, E., Ponka, P., Wilairat, P., Vitolo, M.L., and Webb, J. 1988. Effects of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture. Birth Defects, 23(5B): 81-88.
-
(1988)
Birth Defects
, vol.23
, Issue.5 B
, pp. 81-88
-
-
Richardson, D.1
Baker, E.2
Ponka, P.3
Wilairat, P.4
Vitolo, M.L.5
Webb, J.6
-
125
-
-
0028158768
-
The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell
-
Richardson, D., Ponka, P., and Baker, E. 1994. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res. 54: 685-689.
-
(1994)
Cancer Res.
, vol.54
, pp. 685-689
-
-
Richardson, D.1
Ponka, P.2
Baker, E.3
-
126
-
-
0029030330
-
Nitrogen monoxide decreases iron uptake from transferrin but does not mobilize iron from prelabelled neoplastic cells
-
Richardson, D.R., Neumannova, V., and Ponka, P. 1995a. Nitrogen monoxide decreases iron uptake from transferrin but does not mobilize iron from prelabelled neoplastic cells. Biochim. Biophys. Acta, 1266: 250-260.
-
(1995)
Biochim. Biophys. Acta
, vol.1266
, pp. 250-260
-
-
Richardson, D.R.1
Neumannova, V.2
Ponka, P.3
-
127
-
-
0028891974
-
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents
-
Richardson, D.R., Tran, E., and Ponka, P. 1995b. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood, 86: 4295-4306.
-
(1995)
Blood
, vol.86
, pp. 4295-4306
-
-
Richardson, D.R.1
Tran, E.2
Ponka, P.3
-
128
-
-
0029865751
-
Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: Examination of the intermediates of iron metabolism
-
Richardson, D.R., Ponka, P., and Vyoral, D. 1996. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates of iron metabolism. Blood, 87: 3477-3488.
-
(1996)
Blood
, vol.87
, pp. 3477-3488
-
-
Richardson, D.R.1
Ponka, P.2
Vyoral, D.3
-
129
-
-
0000553206
-
Nicotinoyl and isonicotinoyl hydrazones of pyridoxal
-
Sah, P. 1954. Nicotinoyl and isonicotinoyl hydrazones of pyridoxal. J. Am. Chem. Soc. 76: 300.
-
(1954)
J. Am. Chem. Soc.
, vol.76
, pp. 300
-
-
Sah, P.1
-
130
-
-
0028981308
-
Iron chelation decreases NF-κB and HIV type 1 activation due to oxidative stress
-
Sappey, C., Boelaert, J.R., Legrand-Poels, S., Forceille, C., Favier, A., and Piette, J. 1995. Iron chelation decreases NF-κB and HIV type 1 activation due to oxidative stress. AIDS Res. Hum. Retroviruses, 11: 1049-1061.
-
(1995)
AIDS Res. Hum. Retroviruses
, vol.11
, pp. 1049-1061
-
-
Sappey, C.1
Boelaert, J.R.2
Legrand-Poels, S.3
Forceille, C.4
Favier, A.5
Piette, J.6
-
131
-
-
0015153126
-
Mechanism of inhibition of ribonucleoside diphosphate reductase by α-(N)-heterocyclic aldehyde thiosemicarbazones
-
Sartorelli, A.C., Agrawal, K.C., and Moore, E.C. 1971. Mechanism of inhibition of ribonucleoside diphosphate reductase by α-(N)-heterocyclic aldehyde thiosemicarbazones. Biochem. Pharmacol. 20: 3119-3123.
-
(1971)
Biochem. Pharmacol.
, vol.20
, pp. 3119-3123
-
-
Sartorelli, A.C.1
Agrawal, K.C.2
Moore, E.C.3
-
132
-
-
0027320660
-
Effects of agents that inhibit cellular iron incorporation on bladder cell proliferation
-
Seligman, P.A., Schleicher, R.B., Siriwardana, G., Domenico, J., and Gelfand, E.W. 1993. Effects of agents that inhibit cellular iron incorporation on bladder cell proliferation. Blood, 82: 1608-1617.
-
(1993)
Blood
, vol.82
, pp. 1608-1617
-
-
Seligman, P.A.1
Schleicher, R.B.2
Siriwardana, G.3
Domenico, J.4
Gelfand, E.W.5
-
133
-
-
0026747348
-
Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma
-
Skala, J.P., Rogers, P.C.J., Chan, K.-W, Chao, H.Y., and Rodriguez, W.C. 1992. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma. Prog. Clin. Biol. Res. 377: 71-78.
-
(1992)
Prog. Clin. Biol. Res.
, vol.377
, pp. 71-78
-
-
Skala, J.P.1
Rogers, P.C.J.2
Chan, K.-W.3
Chao, H.Y.4
Rodriguez, W.C.5
-
134
-
-
0026763165
-
A low-spin iron complex in human melanoma and rat hepatoma cells and a high spin iron(II) complex in rat hepatoma cells
-
St.Pierre, T., Richardson, D.R., Baker, E., and Webb, J. 1992. A low-spin iron complex in human melanoma and rat hepatoma cells and a high spin iron(II) complex in rat hepatoma cells. Biochim. Biophys. Acta, 1135: 154-158.
-
(1992)
Biochim. Biophys. Acta
, vol.1135
, pp. 154-158
-
-
St.Pierre, T.1
Richardson, D.R.2
Baker, E.3
Webb, J.4
-
135
-
-
0018777993
-
Studies of desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects
-
Summers, M.R., Jacobs, A., Tudway, D., Perera, P., and Ricketts, C. 1979. Studies of desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br. J. Hematol. 42: 547-555.
-
(1979)
Br. J. Hematol.
, vol.42
, pp. 547-555
-
-
Summers, M.R.1
Jacobs, A.2
Tudway, D.3
Perera, P.4
Ricketts, C.5
-
136
-
-
0021735782
-
Transplasma membrane redox stimulated HeLa cell growth
-
Sun, I.L., Crane, F.L., Löw, H., and Grebing, C. 1984. Transplasma membrane redox stimulated HeLa cell growth. Biochem. Biophys. Res. Commun. 125: 649-654.
-
(1984)
Biochem. Biophys. Res. Commun.
, vol.125
, pp. 649-654
-
-
Sun, I.L.1
Crane, F.L.2
Löw, H.3
Grebing, C.4
-
137
-
-
0019586989
-
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin
-
Sutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J., and Greaves, M. 1981. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc. Natl. Acad. Sci. U.S.A. 78: 4515-4519.
-
(1981)
Proc. Natl. Acad. Sci. U.S.A.
, vol.78
, pp. 4515-4519
-
-
Sutherland, R.1
Delia, D.2
Schneider, C.3
Newman, R.4
Kemshead, J.5
Greaves, M.6
-
138
-
-
0021917196
-
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth
-
Taetle, R., Rhyner, K., Castagnola, D., and Mendelsohn, J. 1985. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. J. Clin. Invest. 75: 1061-1067.
-
(1985)
J. Clin. Invest.
, vol.75
, pp. 1061-1067
-
-
Taetle, R.1
Rhyner, K.2
Castagnola, D.3
Mendelsohn, J.4
-
139
-
-
0024475317
-
Combination iron depletion therapy
-
Taetle, R., Honeysett, J.M., and Bergeron, R. 1989. Combination iron depletion therapy. J. Natl. Cancer Inst. 81: 1229-1235.
-
(1989)
J. Natl. Cancer Inst.
, vol.81
, pp. 1229-1235
-
-
Taetle, R.1
Honeysett, J.M.2
Bergeron, R.3
-
140
-
-
0025879338
-
Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells
-
Terada, N., Lucas, J.J., and Gelfand, E.W. 1991. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147: 698-704.
-
(1991)
J. Immunol.
, vol.147
, pp. 698-704
-
-
Terada, N.1
Lucas, J.J.2
Gelfand, E.W.3
-
141
-
-
0020567471
-
Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone
-
Thelander, L., and Gräslund, A. 1983. Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. J. Biol. Chem. 258: 4063-4066.
-
(1983)
J. Biol. Chem.
, vol.258
, pp. 4063-4066
-
-
Thelander, L.1
Gräslund, A.2
-
143
-
-
0021099095
-
Continual presence of oxygen and iron is required for mammalian ribonucleotide reduction: Possible regulation mechanism
-
Thelander, L., Gräslund, A., and Thelander, M. 1983. Continual presence of oxygen and iron is required for mammalian ribonucleotide reduction: possible regulation mechanism. Biochem. Biophys. Res. Commun. 110: 859-865.
-
(1983)
Biochem. Biophys. Res. Commun.
, vol.110
, pp. 859-865
-
-
Thelander, L.1
Gräslund, A.2
Thelander, M.3
-
144
-
-
0025306383
-
Release of iron from diferric transferrin in the presence of rat liver membranes: No evidence of a diferric transferrin reductase
-
Thorstensen, K., and Aisen, P. 1990. Release of iron from diferric transferrin in the presence of rat liver membranes: no evidence of a diferric transferrin reductase. Biochim. Biophys. Acta, 1052: 29-35.
-
(1990)
Biochim. Biophys. Acta
, vol.1052
, pp. 29-35
-
-
Thorstensen, K.1
Aisen, P.2
-
145
-
-
0027245420
-
Suppression of HL-60 cell proliferation by deferoxamine: Changes in c-myc expression
-
Tomoyasu, S., Fukuchi, K., Yajima, K., Watanabe, K., Suzuki, H., Kawakami, K., Gomi, K., and Tsuruoka, N. 1993. Suppression of HL-60 cell proliferation by deferoxamine: changes in c-myc expression. Anticancer Res. 13: 407-410.
-
(1993)
Anticancer Res.
, vol.13
, pp. 407-410
-
-
Tomoyasu, S.1
Fukuchi, K.2
Yajima, K.3
Watanabe, K.4
Suzuki, H.5
Kawakami, K.6
Gomi, K.7
Tsuruoka, N.8
-
146
-
-
0029953577
-
Transferrin receptor-independent uptake of diferric transferrin by human hepatoma cells with antisense inhibition of receptor expression
-
Trinder, D., Zak, O., and Aisen, P. 1996. Transferrin receptor-independent uptake of diferric transferrin by human hepatoma cells with antisense inhibition of receptor expression. Hepatology, 23: 1512-1520.
-
(1996)
Hepatology
, vol.23
, pp. 1512-1520
-
-
Trinder, D.1
Zak, O.2
Aisen, P.3
-
147
-
-
0000302649
-
Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits tumor cell growth in vitro
-
Trowbridge, I.S., and Lopez, F. 1982. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits tumor cell growth in vitro. Proc. Natl. Acad. Sci. U.S.A. 79: 1175-1179.
-
(1982)
Proc. Natl. Acad. Sci. U.S.A.
, vol.79
, pp. 1175-1179
-
-
Trowbridge, I.S.1
Lopez, F.2
-
148
-
-
0019570604
-
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin
-
Trowbridge, I.S., and Omary, M.B. 1981. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. U.S.A. 78: 3039-3043.
-
(1981)
Proc. Natl. Acad. Sci. U.S.A.
, vol.78
, pp. 3039-3043
-
-
Trowbridge, I.S.1
Omary, M.B.2
-
149
-
-
0027450457
-
Preferential repression of the H-subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts
-
Tsuji, Y., Kwak, E., Saika, T., Torti, S.V., and Torti, F.M. 1993. Preferential repression of the H-subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J. Biol. Chem. 268: 7270-7275.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 7270-7275
-
-
Tsuji, Y.1
Kwak, E.2
Saika, T.3
Torti, S.V.4
Torti, F.M.5
-
150
-
-
0029155970
-
FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression
-
Tsuji, Y., Akebi, N., Lam, T.K., Nakabeppu, Y., Torti, S.V., and Torti, F.M. 1995. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol. Cell. Biol. 15: 5152-5164.
-
(1995)
Mol. Cell. Biol.
, vol.15
, pp. 5152-5164
-
-
Tsuji, Y.1
Akebi, N.2
Lam, T.K.3
Nakabeppu, Y.4
Torti, S.V.5
Torti, F.M.6
-
151
-
-
0030970287
-
Approaches to define pathways of redox regulation of a eukaryotic gene: The heme oxygenase 1 example
-
Tyrrell, R.M. 1997. Approaches to define pathways of redox regulation of a eukaryotic gene: the heme oxygenase 1 example. Methods, 11: 313-318.
-
(1997)
Methods
, vol.11
, pp. 313-318
-
-
Tyrrell, R.M.1
-
152
-
-
0029016627
-
Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells
-
Ul-Haq, R., Wereley, J.P., and Chitambar, C.R. 1995. Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp. Hematol. 23: 428-432.
-
(1995)
Exp. Hematol.
, vol.23
, pp. 428-432
-
-
Ul-Haq, R.1
Wereley, J.P.2
Chitambar, C.R.3
-
153
-
-
0023184215
-
Ferritin content in human cancerous and non-cancerous colonie tissue
-
Vaughn, C.B., Weinstein, R., Bond, B., Rice, R., Vaughn, R.W., McKendrick, A., Ayad, G., Rockwell, M.A., and Rocchio, R. 1987. Ferritin content in human cancerous and non-cancerous colonie tissue. Cancer Invest. 5: 7-10.
-
(1987)
Cancer Invest.
, vol.5
, pp. 7-10
-
-
Vaughn, C.B.1
Weinstein, R.2
Bond, B.3
Rice, R.4
Vaughn, R.W.5
McKendrick, A.6
Ayad, G.7
Rockwell, M.A.8
Rocchio, R.9
-
154
-
-
0000515888
-
Release of iron from ferritin by pyridoxal isonicotinoyl hydrazone and related compounds
-
Vitolo, M.L., Webb, J., and Saltman, P. 1984. Release of iron from ferritin by pyridoxal isonicotinoyl hydrazone and related compounds. J. Inorg. Biochem. 20: 255-262.
-
(1984)
J. Inorg. Biochem.
, vol.20
, pp. 255-262
-
-
Vitolo, M.L.1
Webb, J.2
Saltman, P.3
-
155
-
-
0021356806
-
Iron withholding a defense against infection and neoplasia
-
Weinberg, E.D. 1984. Iron withholding a defense against infection and neoplasia. Physiol. Rev. 64: 65-102.
-
(1984)
Physiol. Rev.
, vol.64
, pp. 65-102
-
-
Weinberg, E.D.1
-
156
-
-
0017135357
-
The effect of chelating agents on cellular iron metabolism
-
White, G.P., Bailey-Wood, R., and Jacobs, A. 1976. The effect of chelating agents on cellular iron metabolism. Clin. Sci. Mol. Med. 50: 145-150.
-
(1976)
Clin. Sci. Mol. Med.
, vol.50
, pp. 145-150
-
-
White, G.P.1
Bailey-Wood, R.2
Jacobs, A.3
-
157
-
-
0018955647
-
The pathogenesis of rat liver cancer caused by chemical carcinogens
-
Williams, G.M. 1980. The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta, 605: 167-189.
-
(1980)
Biochim. Biophys. Acta
, vol.605
, pp. 167-189
-
-
Williams, G.M.1
-
158
-
-
0025602528
-
Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis
-
Wright, J.A., Chan, A.K., Choy, B.K., Hurta, R.A., McClarty, G.A., and Tagger, A.Y. 1990. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis. Biochem. Cell. Biol. 68: 1364-1371.
-
(1990)
Biochem. Cell. Biol.
, vol.68
, pp. 1364-1371
-
-
Wright, J.A.1
Chan, A.K.2
Choy, B.K.3
Hurta, R.A.4
McClarty, G.A.5
Tagger, A.Y.6
|